The Medicines Patent Pool (MPP) Strategy for 2023-2025 outlines a comprehensive plan to enhance global health by ensuring that people in low- and middle-income countries (LMICs) have rapid access to effective and affordable medical treatments and health technologies. The strategy is driven by five key goals:
- Expand access to innovative medicines for infectious diseases, including HIV, TB, and Viral Hepatitis.
- Establish voluntary licensing as an impactful access mechanism for a broader range of diseases and conditions, including non-communicable diseases (NCDs), maternal health, and pediatric needs.
- Facilitate the development and access to novel medical technologies, such as long-acting biologics and mRNA vaccines.
- Accelerate equitable access to countermeasures for pandemics and other international health emergencies like COVID-19.
- Support the diversification and sustainability of manufacturing capacities, including local and regional production, through technology transfer